Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06657235 · ClinicalTrials.gov registry record · NA

Transitional Care Program to Improve Risk Factors in Stroke Survivors

A NA study of Stroke, Ischemic, sponsored by Syntrillo.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT06657235: Recruiting NA study of Stroke, Ischemic, sponsored by Syntrillo.

NCT06657235 is a NA study of Stroke, Ischemic that is actively recruiting participants, run by Syntrillo. The registered enrollment target is 224 participants, below the 283-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06657235, a NA study of Stroke, Ischemic, is actively recruiting participants, sponsored by Syntrillo.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate whether our transitional care program helps stroke survivors better manage their risk factors for stroke to lower the risk of a repeat stroke. The main question it aims to answer is: \- Does the program help participants meet the targets set by the American Heart Association clinical guidelines for control of risk factors associated with stroke? Researchers will compare participants enrolled right after being discharged from the hospital to participants enrolled around 3-5 months after being discharged to examine whether timing differences in enrollment affect the efficacy of the program. Participants will: * Keep track of their medications, their exercise, and their health information using smart devices provided by the study * Answer questions about their health and lifestyle * Meet with our team of healthcare providers

Primary Outcome

We will measure percent compliance with AHA therapeutic standards in the early enrollment group compared to the anticipated baseline percent compliance in the late enrollment group at equivalent time points post-discharge. Percent compliance is a composite endpoint. Participants will be considered "compliant" to secondary stroke prevention guidelines if all other conditions below (2-5) are met. Participants will be considered "non-compliant" to secondary stroke prevention guidelines if one or mo

Conditions Studied

Interventions

  • OTHER Transitional Care Program

Study Locations (1)

Virginia

  • Valley Health System - Winchester

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2024-08-16
Est. Completion 2025-12
Phase NA
Syntrillo

1 total trials

What NCT06657235 shows while recruiting

NCT06657235 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 283-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (21% lower).

The record links to 1 condition, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which Transitional Care Program is the first listed.

NCT06657235 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06657235 about?

NCT06657235 is a clinical study titled "Transitional Care Program to Improve Risk Factors in Stroke Survivors". The goal of this clinical trial is to evaluate whether our transitional care program helps stroke survivors better manage their risk factors for stroke to lower the risk of a repeat stroke. The main question it aims to answer is: \- Does the program help participants meet the targets set by the Ame...

What is the current status of trial NCT06657235?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2024-08-16. Estimated completion is 2025-12.

What conditions does trial NCT06657235 study?

This clinical trial studies the following conditions: Stroke, Ischemic.

What interventions are being tested in trial NCT06657235?

The interventions under investigation include: Transitional Care Program (OTHER).

Who is sponsoring clinical trial NCT06657235?

This trial is sponsored by Syntrillo, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06657235 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Ischemic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06657235's enrollment target sits among peer trials

224 10th of 33 higher than 24 of 33 other Stroke, Ischemic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06657235, the US trial registry maintained by the National Library of Medicine. NCT06657235 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.